Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/2000
06/14/2000CN1053366C Chinese herbal lotion and its prepn.
06/14/2000CN1053361C Producing method of pifule medicine for curing skin disease
06/14/2000CN1053348C Medicine for curing scald and burn
06/13/2000US6075052 Skin external preparation
06/13/2000US6075006 For treatment of arthritis, asthma, inflammation, tumoral growth, gastro intestinal hypermotility, huntington disease, neuritis, neuralgia, migraine, hypertension, incontinence of urine, urticaria, symptoms of the carcinoid syndrome
06/13/2000US6074873 Nucleic acids encoding NL-3
06/13/2000US6074840 Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
06/13/2000US6074839 Transforming growth factor αHI
06/13/2000US6074664 Foil or flat shaped
06/13/2000US6073627 Apparatus for the application of ozone/oxygen for the treatment of external pathogenic conditions
06/13/2000CA2206164C Viscous liquid conditioning topical germicides
06/13/2000CA2147230C Filtering cosmetic compositions containing an acid hydrophilic agent and use thereof
06/13/2000CA2003981C Pharmaceutical compositions and use thereof in the treatment of psoriasis
06/08/2000WO2000032634A1 Humanized antibodies to gamma-interferon
06/08/2000WO2000032624A2 Uncoupling protein 5 - ucp5
06/08/2000WO2000032620A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
06/08/2000WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/08/2000WO2000032593A1 Method of producing paroxetine hydrochloride
06/08/2000WO2000032587A1 Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities
06/08/2000WO2000032584A2 Nonsteroidal antiinflammatories
06/08/2000WO2000032579A1 Substituted benzimidazoles and their use as parp inhibitors
06/08/2000WO2000032575A1 β-ALANINE DERIVATIVES AS α4 INTEGRIN INHIBITORS
06/08/2000WO2000032570A1 Hydrazine derivatives
06/08/2000WO2000032235A1 Transport system conjugate
06/08/2000WO2000032234A1 Topical compositions comprising ascomycins
06/08/2000WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000WO2000032220A1 Anti-dandruff composition comprising an antifungal polypeptide
06/08/2000WO2000032217A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000WO2000032216A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
06/08/2000WO2000032211A1 Enteral pharmaceutical preparation
06/08/2000WO2000032207A1 Spray delivery of cells
06/08/2000WO2000032189A1 Celecoxib compositions
06/08/2000WO2000032184A1 Skin preparations for external use
06/08/2000WO2000032181A1 Method for reducing free-radical induced injury
06/08/2000WO2000032180A2 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituted indolealkanoic acids
06/08/2000WO2000032179A2 Use of nicotonic acid derivatives for the treatment of dna damage in skin cells
06/08/2000WO2000032162A1 Use of plant extracts with an anti-radical-type action
06/08/2000WO2000013693A3 Antipollution plant complex, production process and utilization of said complex in the preparation of pharmaceutical and/or cosmetic compositions
06/08/2000WO2000011191A3 Tpl-2/cot kinase and methods of use
06/08/2000WO2000010592A3 Medicaments for preventing or reducing scarring
06/08/2000DE19854446A1 Use of hyperforin for treating cancer, or in topical compositions optionally together with hypericin for treating e.g. inflammatory skin disease, skin aging or bacterial skin infections
06/08/2000CA2385845A1 Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids
06/08/2000CA2353550A1 Small peptides and methods for treatment of asthma and inflammation
06/08/2000CA2353079A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3
06/08/2000CA2352810A1 Spray delivery of cells
06/08/2000CA2352749A1 Anti-dandruff composition comprising an antifungal polypeptide
06/08/2000CA2352555A1 Transport system conjugate
06/08/2000CA2352367A1 Nonsteroidal antiinflammatories
06/08/2000CA2351321A1 Hydrazine derivatives
06/08/2000CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization
06/08/2000CA2347701A1 .beta.-alanine derivatives as .alpha.4 integrin inhibitors
06/08/2000CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives
06/07/2000EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions
06/07/2000EP1005857A1 O/w-emulsions with a high wax content and their use in the cosmetic and dermatologic fields
06/07/2000EP1005856A1 W/o-emulsions with a high wax content and their use in the cosmetic and dermatologic field
06/07/2000EP1005851A1 Cosmetic or dermatological composition comprising at least one alkynyl carbamate and at least one polyol
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005458A1 Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation
06/07/2000EP1005361A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY
06/07/2000EP1005341A1 Il-8 receptor antagonists
06/07/2000EP1005333A1 Methods and compositions for preventing and treating chronological aging in human skin
06/07/2000EP1005267A1 Phototherapy based method for treating pathogens and composition for effecting same
06/07/2000EP0714304B1 Therapeutic system for treating psoriasis
06/07/2000CN1255373A Medicine for treating multiple skin diseases and its preparing process
06/07/2000CN1255366A Medicine for treating hair pore shrinkage and its preparing process
06/07/2000CN1255360A Antiphlogistic, antalgic and antipruritic medicine for mosquito bite
06/07/2000CN1255357A Grape seed extract with strong anti-tyrosine enzyme activity and its application
06/07/2000CN1255351A Decrustation ointment for burn and its preparing process
06/07/2000CN1053187C Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
06/07/2000CN1053116C Chinese medicinal face film
06/07/2000CN1053109C Spray medicine for burn
06/07/2000CN1053106C Chinese herbs underwear skin-care liquid
06/07/2000CN1053100C Face beautifying cream and preparing method thereof
06/06/2000US6072030 Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them
06/06/2000US6071962 Oxa acids and related compounds for treating skin conditions
06/06/2000US6071948 Treatment of diseases caused by excessive blood vessel growth
06/06/2000US6071930 Method for treating tumors using 2-aryl-naphthyridin-4-ones
06/06/2000US6071919 Stimulate the immunological system and to induce the production of hypercellular bone marrow and extramedullary hematopoiesis; antitumor and -carcinogenic agents; autoimmune diseases; viricides; hepatitis
06/06/2000US6071894 Sensor histidine kinase of Staphylococcus aureus
06/06/2000US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
06/03/2000CA2290847A1 Cosmetic or dermatological composition comprising at least one alkynyl carbamate and at least one polyol
06/03/2000CA2289818A1 Composition in the form of a w/o emulsion with a high-wax content and its cosmetic and dermatological applications
06/02/2000WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031244A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof
06/02/2000WO2000031134A1 Regulation of hair follicle morphogenesis based on beta-catenin
06/02/2000WO2000031083A1 Phospholipid derivatives of non-steroidal anti-inflammatory drugs
06/02/2000WO2000031081A2 Amino- and mercurio-substituted 4',5'-dihydropsoralens and therapeutical uses thereof
06/02/2000WO2000031067A1 Propanoic acid derivatives as integrin inhibitors
06/02/2000WO2000031060A1 Scavenger compounds
06/02/2000WO2000031054A1 Il-5 inhibiting 6-azauracil derivatives
06/02/2000WO2000031051A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031049A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031048A1 N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
06/02/2000WO2000031038A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands
06/02/2000WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000WO2000031033A1 Piperidine ccr-3 receptor antagonists
06/02/2000WO2000030650A1 Desmethylolanzapine compositions and methods
06/02/2000WO2000030636A1 Use of pyrethroid compounds to promote hair growth
06/02/2000WO2000030622A2 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
1 ... 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 ... 1065